IVERIC bio Inc is a United States-based gene therapy focused company developing treatments for patients with orphan inherited retinal diseases with unmet medical needs. Its gene therapy is a technology that seeks to correct a faulty gene by providing a healthy gene replacement, through a single treatment, resulting in the expression of a therapeutic protein that was otherwise not being produced.
AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in the development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline. https://www.zentaris.com/